Sale!

NEXN Gene Cardiomyopathy Dilated Type 1CC Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “NEXN Gene Cardiomyopathy Dilated Type 1CC Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the NEXN gene that are associated with Dilated Cardiomyopathy (DCM) of type 1CC. DCM is a condition characterized by the enlargement and weakening of the heart’s main pumping chamber, which can lead to heart failure and other serious complications. The NEXN gene plays a crucial role in the structural integrity and function of heart muscle cells, and mutations in this gene can disrupt these processes, leading to the development of DCM.

The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the NEXN gene. It is particularly useful for individuals with a family history of DCM or those exhibiting symptoms suggestive of the condition, as early detection can enable timely intervention and management strategies to mitigate the progression of the disease.

Offered at a cost of 4400 AED, this genetic test is a significant advancement in the field of personalized medicine, allowing for a more tailored approach to the diagnosis, treatment, and management of Dilated Cardiomyopathy. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic diagnostics, provides a reliable and efficient service for individuals seeking to understand their genetic risk for this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test

At DNA Labs UAE, we offer the NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test. This test is designed to analyze the NEXN gene for mutations associated with dilated cardiomyopathy (DCM), specifically the dilated type 1CC subtype.

Test Details

The NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test is a genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the NEXN gene for any disease-causing mutations. This test is specifically focused on identifying mutations associated with dilated cardiomyopathy.

Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy, in particular, is characterized by the enlargement and weakened pumping ability of the heart chambers.

The NEXN gene provides instructions for producing a protein called Nexilin, which plays a crucial role in maintaining the structure and function of heart muscle cells. Mutations in the NEXN gene can disrupt the normal functioning of Nexilin, leading to the development of dilated cardiomyopathy.

Test Components and Price

The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is priced at 4400.0 AED. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery and Method

The report for the NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is typically delivered within 3 to 4 weeks. The test utilizes NGS technology for accurate and efficient analysis of the NEXN gene.

Test Type and Doctor

The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult a cardiologist for this specific genetic test.

Test Department and Pre Test Information

The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test is conducted in the Genetics department. It is essential to provide the clinical history of the patient who is undergoing the test, along with a genetic counseling session to draw a pedigree chart of family members affected by NEXN Gene Cardiomyopathy.

Importance of the Test

The NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test helps identify individuals who have an increased risk of developing dilated cardiomyopathy due to NEXN gene mutations. Understanding the genetic cause of dilated cardiomyopathy is crucial for its diagnosis, management, and treatment. Additionally, it provides valuable information for family members who may be at risk of inheriting the mutation.

It is important to note that this genetic test should be performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics and cardiology.

Test Name NEXN Gene Cardiomyopathy dilated type 1CC Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic DNA Test gene NEXN
Test Details

NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test is a genetic test that analyzes the NEXN gene for mutations associated with dilated cardiomyopathy (DCM), specifically the dilated type 1CC subtype.

Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormal heart function. Dilated cardiomyopathy is characterized by the enlargement and weakened pumping ability of the heart chambers.

The NEXN gene provides instructions for producing a protein called Nexilin, which is involved in maintaining the structure and function of heart muscle cells. Mutations in the NEXN gene can disrupt the normal functioning of Nexilin, leading to the development of dilated cardiomyopathy.

The NEXN Gene Cardiomyopathy, dilated type 1CC NGS Genetic Test uses Next-Generation Sequencing (NGS) technology to analyze the NEXN gene for any disease-causing mutations. This test can help identify individuals who have an increased risk of developing dilated cardiomyopathy due to NEXN gene mutations.

Knowing the genetic cause of dilated cardiomyopathy can help in the diagnosis, management, and treatment of the condition. It can also provide valuable information for family members who may be at risk of inheriting the mutation.

It is important to note that this genetic test is typically performed in a clinical setting, and the results should be interpreted by a healthcare professional with expertise in genetics and cardiology.